High Flow nasal canula oxygen therapy
ProcedurePre-oxygenation with high-flow nasal canula oxygen therapy
NCT Number: NCT02668458
The aim of the study is to evaluate the incidence of severe hypoxemia episodes during the intubation procedure with two methods of pre-oxygenation:
1. NIV (Non Invasive Ventilation) 2. HFNC (High-flow nasal canula oxygen therapy)
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
CHU Angers, Angers, France
Design:
Clinical randomized, open, multicenter, comparative trial, with parallel groups aimed at evaluating a medical device.
Selection of patients admitted to the ICU for acute respiratory failure, requiring endotracheal intubation.
Randomized study, inclusion in two groups: NIV or HFNC.
Experimental group:
NHFC group, preoxygenation by NHFC: oxygen flow rate of 60 L / min and 100% FiO2.
Control group:
NIV group, preoxygenation by NIV: pressure support set for an exhaled tidal volume of 6-8 ml / kg of ideal body weight, PEEP of 5 cm H2O and FiO2 at 100%.
Duration of participation of each patient: 28 days
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Main inclusion Criteria:
Main exclusion Criteria:
Pre-oxygenation with high-flow nasal canula oxygen therapy
Pre-oxygenation with non-invasive ventilation
Time frame: through five minutes after preoxygenation period
drop below 80% of pulse oxymetry measurement
Poitiers University Hospital
Other
Comparison of Pre-oxygenation by Non-invasive Ventilation With High-flow Nasal Oxygen Therapy for Intubation of Intensive Care Patients in Cases of Acute Respiratory Failure: A Prospective, Randomized, Controlled Study (FLORALI 2)
Acronym: FLORALI2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06876168
Acute Respiratory Failure, Infections
Lexington, Kentucky, United States
View Trial DetailsNCT02723565
Acute Respiratory Failure, Pathologic Processes
Toronto, Ontario, Canada
View Trial DetailsNCT07366541
Acute Respiratory Failure, Electrical Impedance Tomography (EIT)
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05423301
Acute Respiratory Failure
Pessac, France
View Trial Details